ask="7.20"
ask_size="700"
average_daily_volume="42389"
bid="4.50"
bid_size="2000"
book_value="5.08"
change="-0.28"
change_from_200_day_moving_average="-1.04"
change_from_50_day_moving_average="-0.61"
change_from_52_week_high="-8.14"
change_From_52_week_low="0.72"
change_in_percent="-5.73%"
close="4.61"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-3.06"
ebitda="-20.26M"
eps_estimate_current_year="-8.61"
eps_estimate_next_quarter="-0.80"
eps_estimate_next_year="-2.57"
ex_dividend_date="N/A"
float_shares="6404000"
high="4.90"
high_52_weeks="12.75"
last_trade_date="1/20/2017"
last_trade_price="4.61"
last_trade_size="200"
last_trade_time="3:59pm"
low="4.60"
low_52_weeks="3.89"
market_capitalization="61.91M"
moving_average_200_day="5.65"
moving_average_50_day="5.22"
name="Aeglea BioTherapeutics
Inc."
notes="N/A"
one_year_target_price="17.00"
open="4.90"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-18.39%"
percent_change_from_50_day_moving_average="-11.70%"
percent_change_from_52_week_high="-63.84%"
percent_change_from_52_week_low="+18.51%"
previous_close="4.89"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="0.96"
price_per_sales="13.22"
revenue="4.97M"
shares_outstanding="13430000"
short_ratio="0.55"
stock_exchange="NGM"
symbol="AGLE"
volume="13124"
weeks_range_52="3.89 - 12.75"
